当前位置:首页 - 行情中心 - 新芝生物(920685) - 财务分析 - 现金流量表

新芝生物

(920685)

  

流通市值:6.58亿  总市值:10.51亿
流通股本:5567.65万   总股本:8887.85万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金157,125,874.2694,754,373.7940,736,357.63207,006,948.67
  收到的税费返还4,832,427.983,042,332.691,543,345.264,334,509.64
  收到其他与经营活动有关的现金3,902,737.323,134,144.172,399,286.423,736,149.08
  经营活动现金流入小计165,861,039.56100,930,850.6544,678,989.31215,077,607.39
  购买商品、接受劳务支付的现金62,501,497.0944,386,481.2322,246,678.6652,273,011.89
  支付给职工以及为职工支付的现金56,255,819.1441,518,486.8926,158,928.6263,407,048.81
  支付的各项税费18,290,225.0212,200,509.745,460,116.5322,020,396.55
  支付其他与经营活动有关的现金14,451,642.459,036,131.794,068,634.9816,246,049.52
  经营活动现金流出小计151,499,183.7107,141,609.6557,934,358.79153,946,506.77
  经营活动产生的现金流量净额14,361,855.86-6,210,759-13,255,369.4861,131,100.62
二、投资活动产生的现金流量:
  收回投资收到的现金660,400,000429,400,000111,000,000884,500,000
  取得投资收益收到的现金3,707,921.472,478,114.06997,202.93,861,887.98
  处置固定资产、无形资产和其他长期资产收回的现金净额11,500--540,292.25
  投资活动现金流入小计664,119,421.47431,878,114.06111,997,202.9888,902,180.23
  购建固定资产、无形资产和其他长期资产支付的现金10,162,292.844,335,781.77936,990.0238,472,216.41
  投资支付的现金654,700,000416,700,00076,000,000882,200,000
  投资活动现金流出小计664,862,292.84421,035,781.7776,936,990.02920,672,216.41
  投资活动产生的现金流量净额-742,871.3710,842,332.2935,060,212.88-31,770,036.18
三、筹资活动产生的现金流量:
  取得借款收到的现金12,500,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计12,500,000---
  分配股利、利润或偿付利息支付的现金17,442,126.5217,435,155.695,880,952.3825,045,746.71
  其中:子公司支付给少数股东的股利、利润--5,880,952.389,047,619.05
  支付其他与筹资活动有关的现金9,447,213.698,480,108.527,825,286.572,992,132.37
  筹资活动现金流出小计26,889,340.2125,915,264.2113,706,238.9528,037,879.08
  筹资活动产生的现金流量净额-14,389,340.21-25,915,264.21-13,706,238.95-28,037,879.08
四、汇率变动对现金及现金等价物的影响-662,483.7-472,097.42-226,855.21-177,192.74
五、现金及现金等价物净增加额-1,432,839.42-21,755,788.347,871,749.241,145,992.62
  加:期初现金及现金等价物余额96,585,915.596,585,915.596,585,915.595,439,922.88
  期末现金及现金等价物余额95,153,076.0874,830,127.16104,457,664.7496,585,915.5
补充资料:
  净利润-18,829,136.88-43,699,136.64
  资产减值准备-1,058,989.41-3,098,757.73
  固定资产和投资性房地产折旧-2,325,783.36-4,456,342.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,325,783.36-4,456,342.9
  无形资产摊销-133,259.62-1,038,978.46
  长期待摊费用摊销-426,050.79-920,406.77
  处置固定资产、无形资产和其他长期资产的损失----145,904.27
  固定资产报废损失-504.3-204,343.31
  公允价值变动损失--1,450,821.09--3,377,216.92
  财务费用-583,348.34-344,812.24
  投资损失--904,942.22--1,901,592.31
  递延所得税--314,576.73--92,213.46
  其中:递延所得税资产减少--310,976.53--88,010.58
    递延所得税负债增加--3,600.2--4,202.88
  存货的减少--25,271,820.13--10,294,277.38
  经营性应收项目的减少--8,484,363.77-7,445,434.68
  经营性应付项目的增加-5,293,369.07-12,390,418.74
  其他--251,536.87--
  现金的期末余额-74,830,127.16-96,585,915.5
  减:现金的期初余额-96,585,915.5-95,439,922.88
  现金及现金等价物的净增加额--21,755,788.34-1,145,992.62
公告日期2026-10-272026-08-262026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑